CEO Richard Resnick talks about the importance of having investors on the ground.
Richard Resnick, CEO
The strength of our portfolio is rooted in the world class visionaries who lead these companies. Together we are creating the next generation of HealthTech.
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions.
Andros (formerly known as CredSimple) is an NCQA-certified SaaS company automating the provider credentialing process for healthcare providers and payors.
A mentorship-driven startup accelerator program for entrepreneurs involved in the health technology space. Blueprint provides funding, co-working space and guidance to these companies from a sizable network of mentors.
Coravin markets the Coravin Wine Access System for wine enthusiasts, restaurants, wine stores and wineries. Coravin developed proprietary patented technology to access and pour wine from a bottle without pulling the cork.
CVRx is a clinical stage company that has developed proprietary active implantable technology for the treatment of hypertension and heart failure.
Cartiva develops and markets innovative solutions for patients with osteoarthritis, cartilage damage and other musculoskeletal conditions.
ChromaCode’s High-Definition PCR (HDPCRTM) combines proprietary data science with established, low-cost chemistries. They greatly enhance the multiplexing capability of standard qPCR and dPCR machines, thereby lowering cost and democratizing access to molecular diagnostic testing.
ClarVista is a medical device company focused on novel solutions in ophthalmology. Clarvista is developing the HARMONI Modular Intra-Ocular System to optimize vision in the setting of cataract surgery.
Clever Care is an emerging Medicare Advantage plan that provides culturally sensitive health care solutions and offers its members the best of Eastern and Western medicine
ControlRad is a medical technology company focused on reducing radiation exposure to healthcare providers and patients during a wide spectrum of medical procedures.
Cureatr is a NY-based company providing medication management telepharmacy services, committed to tackling the $528B suboptimal medication management problem.
DOTS (Detection on the Spot) is commercializing a novel food allergen detection system to test food on the spot, spanning both industrial and consumer applications.
Delfi Diagnostics is developing proprietary liquid biopsy-based diagnostic technology for the early detection of cancer.
Earlens has developed and is marketing a novel hearing solution designed to change the current standard of care for hearing impaired individuals. The Earlens System's unique mechanism of direct sound delivery achieves a level of sound quality unmatched by conventional hearing aids.
Fore Biotherapeutics (formerly Novellus) provides functional information about mutations and their response to drugs, enabling oncologists to treat cancer patients with precision therapies and bio-pharmaceutical companies to develop new drugs more effectively.
GlySens has developed a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices.
Invuity (NASDAQ:IVTY) markets sophisticated optics for illumination and enhanced visualization in surgery.
Locemia is a specialty diabetes-focused pharmaceutical company committed to bringing innovation to severe hypoglycemia rescue through a simpler, needle-free solution.
MC10 is extending human capabilities by making high performance, electronics virtually invisible, conformable and wearable.
Nebula Genomics is a human genome sequencing and health “big data” company on a mission to usher in the mass adoption of gene sequencing by building a large and trusted genomic and healthcare data marketplace for consumers, researchers, and the medical community.
NeoTract is marketing a novel, office-based, minimally invasive approach for treating benign prostatic hyperplasia. The device provides rapid and long-term relief of obstructive symptoms and does not preclude any other form of therapy, medical or surgical.
NeuSpera, based in Santa Clara, CA, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology.
NovoCure (NASDAQ:NVCR) has developed a novel form of cancer therapy termed Tumor Treatment Fields (TTF) that operates on different principles than standard treatment modalities (surgery, radiation and chemotherapy).
Nuelle is a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women.
Nuvaira is developing a first-in-class bronchoscopic device and procedure to treat lung diseases, including chronic obstructive pulmonary disease (COPD) and asthma.
Personal Genome Diagnostics (PGDx) is an emerging leader in personalized diagnostics with a proprietary methodology in next generation sequencing (NGS) for use in research and clinical oncology.
Revelle Aesthetics, the latest ExploraMed Company, is developing a novel medical device in aesthetics.
RxWare (formerly HelpAround) provides specialty pharma brands services to augment existing patient access, activation and adherence programs with multi-modal mobile navigation.
Science Exchange is an online marketplace for scientific collaboration where researchers can order experiments from the world's best laboratories.
SubjectWell is building the first and only marketplace of patients for clinical trial recruitment.
Upward Health (formerly known as BehaveCare) is an at-risk care coordination company focused on improving outcomes and reducing healthcare costs for certain Medicaid populations.
Valera Health is a Brooklyn, NY based tele-mental health company which partners with health plans, employers and primary care practices to deliver comprehensive mental health services to patients.
Vergent Bioscience has developed VGT-309, a targeted fluorescent imaging agent that enables surgeons to see previously undetected or difficult-to-find tumors in real-time, ensuring all tumor tissue is removed during open, minimally invasive (MIS) and robotic-assisted surgical procedures.
VytronUS is a clinical stage, medical device company developing a novel catheter-based treatment for cardiac arrhythmias with a focus on atrial fibrillation (AFib).
WellDoc has developed an industry-leading, technology-based platform designed to help people with chronic diseases manage their conditions. The company is initially focused on type II diabetes.
Willow Pump is the first wearable smart breast pump, allowing new mothers to be liberated from wires while discreetly pumping. Willow Pump mobile app allows users to connect on smartphones or tablets via Bluetooth in order to track milk volume in real time, compare data from previous sessions, set alerts, and more.